Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.660
+0.010 (0.61%)
Mar 17, 2026, 11:00 AM EDT - Market open
Geron Employees
Geron had 258 employees as of December 31, 2025. The number of employees increased by 29 or 12.66% compared to the previous year.
Employees
258
Change (1Y)
29
Growth (1Y)
12.66%
Revenue / Employee
$712,717
Profits / Employee
-$323,643
Market Cap
1.06B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 258 | 29 | 12.66% | 258 | 0 |
| Dec 31, 2024 | 229 | 88 | 62.41% | 229 | 0 |
| Dec 31, 2023 | 141 | 34 | 31.78% | 141 | 0 |
| Dec 31, 2022 | 107 | 35 | 48.61% | 107 | 0 |
| Dec 31, 2021 | 72 | 17 | 30.91% | 69 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 562 |
| Xeris Biopharma Holdings | 435 |
| Pharming Group | 404 |
| uniQure | 221 |
| Inhibrx Biosciences | 161 |
| Monte Rosa Therapeutics | 147 |
| Olema Pharmaceuticals | 122 |
| ArriVent BioPharma | 77 |
GERN News
- 6 days ago - Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 18 days ago - Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings - Seeking Alpha
- 19 days ago - Geron Corporation (GERN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 22 days ago - Geron Plans to Present at Upcoming Investor Conferences - GlobeNewsWire
- 26 days ago - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 27 days ago - Top 3 Health Care Stocks That May Collapse This Quarter - Benzinga
- 4 weeks ago - Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - GlobeNewsWire